{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:37:16Z","timestamp":1789659436643,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"3M"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jgar.2018.12.008","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T20:02:51Z","timestamp":1545422571000},"page":"160-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Evaluation of activity and potential for development of antimicrobial resistance to a new tinted 2% chlorhexidine gluconate\/70% isopropyl alcohol film-forming sterile preoperative skin preparation"],"prefix":"10.1016","volume":"17","author":[{"given":"Kathryn","family":"Dormstetter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda K.M.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assumpta","family":"Bennaars-Eiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie F.","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.12.008_bib0005","first-page":"190","article-title":"Skin preparation for the prevention of surgical site infection: which agent is best?","volume":"11","author":"Hemani","year":"2009","journal-title":"Rev Urol"},{"key":"10.1016\/j.jgar.2018.12.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044277","article-title":"The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis","volume":"7","author":"Maiwald","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.jgar.2018.12.008_bib0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijsu.2017.06.001","article-title":"Preoperative chlorhexidine versus povidone-iodine antisepsis for preventing surgical site infection: a meta-analysis and trial sequential analysis of randomized controlled trials","volume":"44","author":"Zhang","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.jgar.2018.12.008_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/CMR.00049-15","article-title":"Decolonization in prevention of health care-associated infections","volume":"29","author":"Septimus","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.jgar.2018.12.008_bib0025","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1128\/AAC.02595-15","article-title":"Chlorhexidine induces VanA-type vancomycin resistance genes in enterococci","volume":"60","author":"Bhardwaj","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.008_bib0030","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1021\/acs.jafc.6b04650","article-title":"Adaptation to biocides cetrimide and chlorhexidine in bacteria from organic foods: association with tolerance to other antimicrobials and physical stresses","volume":"65","author":"Gadea","year":"2017","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jgar.2018.12.008_bib0035","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1099\/jmm.0.000487","article-title":"Chlorhexidine whole-body washing of patients reduces methicillin-resistant Staphylococcus aureus and has a direct effect on the distribution of the ST5-MRSA-II (New York\/Japan) clone","volume":"66","author":"Velazquez-Meza","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2018.12.008_bib0040","first-page":"61","article-title":"Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of klebsiella pneumoniae clinical isolates to chlorhexidine","author":"Wand","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.12.008_bib0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/CMR.00112-16","article-title":"Current and emerging topical antibacterials and antiseptics: Agents, action, and resistance patterns","volume":"30","author":"Williamson","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2018.12.008_bib0050","first-page":"97","article-title":"Guideline for prevention of surgical site infection, 1999","author":"Mangram","year":"1999","journal-title":"Committee HICPA"},{"key":"10.1016\/j.jgar.2018.12.008_bib0055","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1111\/j.1469-0691.2011.03752.x","article-title":"The role of pharmacokinetics\/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach","volume":"18","author":"Mouton","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2018.12.008_bib0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/jp.2011.148","article-title":"Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant","volume":"32","author":"Chapman","year":"2012","journal-title":"J Perinatol"},{"key":"10.1016\/j.jgar.2018.12.008_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diagmicrobio.2008.11.014","article-title":"Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility","volume":"63","author":"Sheng","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.008_bib0070","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/jac\/dkw282","article-title":"Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs","volume":"71","author":"Lahiri","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.12.008_bib0075","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/jac\/dkv228","article-title":"In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure","volume":"70","author":"Sole","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.12.008_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mimet.2018.08.011","article-title":"In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants","volume":"153","author":"Ismail","year":"2018","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.jgar.2018.12.008_bib0085","series-title":"M07-A10 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard","author":"CLSI","year":"2015"},{"key":"10.1016\/j.jgar.2018.12.008_bib0090","series-title":"ASTM E2315-03. Standard guide for assessment of antimicrobial activity using a time-kill procedure","author":"ASTM","year":"2008"},{"key":"10.1016\/j.jgar.2018.12.008_bib0095","series-title":"Manual of clinical microbiology","author":"Balows","year":"1991"},{"key":"10.1016\/j.jgar.2018.12.008_bib0100","series-title":"ASTM E1054-08 (Reapproved 2013): Standard test methods for evaluation of inactivators of antimicrobial agents","author":"ASTM","year":"2013"},{"key":"10.1016\/j.jgar.2018.12.008_bib0105","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved Standard","author":"CLSI M07-A8","year":"2009"},{"key":"10.1016\/j.jgar.2018.12.008_bib0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0195-6701(93)90109-D","article-title":"Antibacterial activity of chlorhexidine","volume":"25","author":"Russell","year":"1993","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2018.12.008_bib0115","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0195-6701(99)90066-X","article-title":"Bacterial resistance to disinfectants: present knowledge and future problems","volume":"43","author":"Russell","year":"1998","journal-title":"J Hospital Infect"},{"key":"10.1016\/j.jgar.2018.12.008_bib0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/1120009X.2009.12030920","article-title":"Bacterial biocide resistance","volume":"21","author":"Tumah","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2018.12.008_bib0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhin.2014.04.012","article-title":"Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point\/counterpoint review","volume":"87","author":"Harbarth","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2018.12.008_bib0130","article-title":"Ex vivo and in vivo evaluation of residual chlorhexidine gluconate on skin following repetitive exposure to saline and wiping of 2% chlorhexidine gluconate\/70% isopropyl alcohol preoperative skin preparations","author":"Hamid Bashir","year":"2018","journal-title":"J Hospital Infect"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T16:46:57Z","timestamp":1560876417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518302522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":26,"alternative-id":["S2213716518302522"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.12.008","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of activity and potential for development of antimicrobial resistance to a new tinted 2% chlorhexidine gluconate\/70% isopropyl alcohol film-forming sterile preoperative skin preparation","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}